Meet our Students Button  

The Office of Admissions recruits and matriculates those individuals most likely to enhance the overall health of our local, regional, national and international communities through the development of new knowledge and the provision of exemplary patient care. Each year, the School of Medicine matriculates a group of talented individuals who reflect the growing ethnic and cultural diversity of present day society, drawing on the knowledge and skills of individuals from all segments of society. Learn more about our Vision & Values.

Through innovative identification, recruitment and development programs, the School of Medicine has become recognized for the rich diversity of its student body. The Committee on Admissions has the daunting yet important job of selecting an outstanding entering freshman class each year from a bright, dedicated and diverse pool of applicants. The Committee will admit only those individuals who demonstrate the intellectual curiosity necessary for a lifetime of learning and who the Committee believes will maintain the highest standards of ethical and professional conduct.

Our students are our most prized asset and our dedicated faculty takes great joy and pride in helping each and every one of them develop into our future colleagues in the profession of medicine.

  • University of Maryland School of Medicine Announces Appointment of Chancellor Brit Kirwan, Other Prominent Leaders to its Board

    University of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, and UM SOM Board of Visitors Chairman, Michael E. Cryor today announced the appointment of new board members, including prominent leaders from academia, business and law.

  • First-Ever Possible Treatments for Middle East Respiratory Syndrome; UMSOM Researchers Identify Two Promising Candidates to Prevent and Treat Deadly Epidemic

    University of Maryland School of Medicine scientists and Regeneron Pharmaceuticals, Inc., have discovered and validated two therapeutics that show early promise in preventing and treating MERS, which can cause severe respiratory symptoms, and has a death rate of 40 percent.

  • University of Maryland School of Medicine Scientist Identifies “Decoy" Molecule That Could Help Sharply Reduce Risk of Flu Death

    The influenza virus can be lethal to those who are infected. But what is often just as dangerous is the body’s own reaction to the virus. This immune response consists of an inflammatory attack, meant to kill the virus. But if it gets too aggressive, this counterattack can end up harming the body’s own tissues, causing damage that can easily lead to death in vulnerable patients.

  • University of Maryland School of Medicine to Collaborate in New Center for Sports Medicine, Health and Human Performance

    University of Maryland School of Medicine Dean E. Albert Reece, MD, PhD, MBA, announced today that the University of Maryland School of Medicine (UM SOM) will collaborate with the University of Maryland, College Park (UMCP) on a new center to study athletic performance and health. The Center for Sports Medicine, Health and Human Performance will employ innovative diagnostics and treatments for a broad spectrum of athletic injuries. Faculty physicians from the UM SOM will treat sports-related injuries in UMCP student-athletes, other students and the general public. These research efforts will focus on a range of areas, including concussion, traumatic brain injury, muscle-brain physiology and biochemistry, exoskeleton-robotic treatments and clinical and medical biomechanics.

  • Institute of Human Virology (IHV) Awarded $24.5M to Fight Botswana’s AIDS Epidemic

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine has received a five-year $24.5 million grant from the U.S. Centers for Disease Control and Prevention (CDC) through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) to partner with the Government of Botswana and impact the HIV/AIDS epidemic in Botswana, and to demonstrate that comprehensive HIV/AIDS treatment programs can stop the epidemic. PEPFAR is a $48 billion initiative launched in 2004 by former President George W. Bush, and continued by President Barack Obama, to combat major infectious diseases around the world, including HIV.

News Archive » Submit News » RSS

Download the Admissions Brochure